Molecular Partners AG
SIX:MOLN
Molecular Partners AG
Total Current Liabilities
Molecular Partners AG
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Molecular Partners AG
SIX:MOLN
|
Total Current Liabilities
CHf11m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Total Current Liabilities
$149.1m
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
31%
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Total Current Liabilities
CHf49.2m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-3%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Total Current Liabilities
CHf160.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Total Current Liabilities
CHf27m
|
CAGR 3-Years
27%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
|
Relief Therapeutics Holding SA
SIX:RLF
|
Total Current Liabilities
CHf3.8m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Molecular Partners AG
Glance View
Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The company is headquartered in Schlieren, Zuerich and currently employs 163 full-time employees. The company went IPO on 2014-10-22. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
See Also
What is Molecular Partners AG's Total Current Liabilities?
Total Current Liabilities
11m
CHF
Based on the financial report for Dec 31, 2025, Molecular Partners AG's Total Current Liabilities amounts to 11m CHF.
What is Molecular Partners AG's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
-28%
Over the last year, the Total Current Liabilities growth was 2%. The average annual Total Current Liabilities growth rates for Molecular Partners AG have been -14% over the past three years , -28% over the past five years .
